Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin P Mitchell

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Schizophrenia Bulletin|July 29, 2004
What is the functional significance of hippocampal pathology in schizophrenia?Morris B Goldman, Colin P Mitchell
Physiology & Behavior|April 7, 2005
Differential effects of removing the glucose or saccharin components of a glucose-saccharin mixture in a successive negative contrast paradigmColin P Mitchell, Charles F Flaherty
Psychoneuroendocrinology|August 4, 2004
Neonatal lesions of the ventral hippocampal formation disrupt neuroendocrine responses to auditory stress in the adult ratColin P Mitchell, Morris B Goldman
Biological Psychiatry|December 21, 2004
Neonatal lesions of the ventral hippocampal formation alter GABA-A receptor subunit mRNA expression in adult rat frontal poleColin P Mitchell, Dennis R Grayson, Morris B Goldman
Pharmacology, Biochemistry, and Behavior|December 8, 2004
Evidence for zolpidem-induced hyperphagia, but not anxiolysis, in a successive negative contrast paradigmColin P Mitchell, Mary Leszczuk Ost, Charles F Flaherty
Journal of Neurochemistry|April 9, 2005
Histone deacetylase inhibitors decrease reelin promoter methylation in vitroColin P Mitchell, Ying Chen, Marija Kundakovic, et al.
Critical Reviews in Neurobiology|February 24, 2004
GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerabilityErminio Costa, Dennis R Grayson, Colin P Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2005
Reelin promoter hypermethylation in schizophreniaDennis R Grayson, Xiaomei Jia, Ying Chen, et al.
Clinical Therapeutics|July 25, 2006
A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjectsMalcolm Mitchell, Robert Riesenberg, Mohammad A Bari, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2021
Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MSJens Kuhle, Nadia Daizadeh, Pascal Benkert, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Schizophrenia Bulletin|July 29, 2004
What is the functional significance of hippocampal pathology in schizophrenia?Morris B Goldman, Colin P Mitchell
Physiology & Behavior|April 7, 2005
Differential effects of removing the glucose or saccharin components of a glucose-saccharin mixture in a successive negative contrast paradigmColin P Mitchell, Charles F Flaherty
Psychoneuroendocrinology|August 4, 2004
Neonatal lesions of the ventral hippocampal formation disrupt neuroendocrine responses to auditory stress in the adult ratColin P Mitchell, Morris B Goldman
Biological Psychiatry|December 21, 2004
Neonatal lesions of the ventral hippocampal formation alter GABA-A receptor subunit mRNA expression in adult rat frontal poleColin P Mitchell, Dennis R Grayson, Morris B Goldman
Pharmacology, Biochemistry, and Behavior|December 8, 2004
Evidence for zolpidem-induced hyperphagia, but not anxiolysis, in a successive negative contrast paradigmColin P Mitchell, Mary Leszczuk Ost, Charles F Flaherty
Journal of Neurochemistry|April 9, 2005
Histone deacetylase inhibitors decrease reelin promoter methylation in vitroColin P Mitchell, Ying Chen, Marija Kundakovic, et al.
Critical Reviews in Neurobiology|February 24, 2004
GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerabilityErminio Costa, Dennis R Grayson, Colin P Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2005
Reelin promoter hypermethylation in schizophreniaDennis R Grayson, Xiaomei Jia, Ying Chen, et al.
Clinical Therapeutics|July 25, 2006
A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjectsMalcolm Mitchell, Robert Riesenberg, Mohammad A Bari, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2021
Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MSJens Kuhle, Nadia Daizadeh, Pascal Benkert, et al.
Pageof 2